Picton Mahoney Asset Management Boosts Stock Holdings in Charles River Laboratories International, Inc. $CRL

robot
Abstract generation in progress

Picton Mahoney Asset Management significantly increased its stake in Charles River Laboratories International (NYSE:CRL) by 126.9% in Q3, now holding 78,309 shares valued at $12.25 million. Analyst sentiment for CRL is largely positive, with an average price target of $203.57, including recent upgrades, while the company slightly beat its recent earnings and revenue estimates. Charles River Laboratories operates in the medical research sector, providing research models and support services for pharmaceutical, biotechnology, and medical device industries.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin